Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed to reflect the latest page template. No study data or content related to the trial details, eligibility, or results was changed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice plus Revision: v3.4.1; these updates are administrative and do not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNotice about government funding affecting site operations is shown. The page now lists Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedThe changes are cosmetic metadata updates (glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act labeling, and Revision: v3.4.0) that do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedNew document revision v3.3.4 replaces v3.3.3, a minor metadata update with no change to core study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page adds a Locations section showing three study sites (Duarte, CA; Aurora, CO; Philadelphia, PA) and their institutions, and displays a Revision: v3.3.3 tag.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.